Registration - Amendment

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

Firm
Client
Income
—
Expenses
—

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

PHARMACEUTICALS

LobbyistCovered position, as disclosed
JOHN DEL GIORNO New —
GARY HEIMBERG New —
WILLIAM J SCHUYLER New —
SARAH J WALSH New —
KIMBERLY A WILLIAMS New —

Medicare/Medicaid MMM

PHARMACEUTICALS

LobbyistCovered position, as disclosed
JOHN DEL GIORNO New —
GARY HEIMBERG New —
WILLIAM J SCHUYLER New —
SARAH J WALSH New —
KIMBERLY A WILLIAMS New —

Taxation/Internal Revenue Code TAX

PHARMACEUTICALS

LobbyistCovered position, as disclosed
JOHN DEL GIORNO New —
GARY HEIMBERG New —
WILLIAM J SCHUYLER New —
SARAH J WALSH New —
KIMBERLY A WILLIAMS New —

Copyright/Patent/Trademark CPT

PHARMACEUTICALS

LobbyistCovered position, as disclosed
JOHN DEL GIORNO New —
GARY HEIMBERG New —
WILLIAM J SCHUYLER New —
SARAH J WALSH New —
KIMBERLY A WILLIAMS New —

Budget/Appropriations BUD

PHARMACEUTICALS

LobbyistCovered position, as disclosed
JOHN DEL GIORNO New —
GARY HEIMBERG New —
WILLIAM J SCHUYLER New —
SARAH J WALSH New —
KIMBERLY A WILLIAMS New —

Government Issues GOV

PHARMACEUTICALS

LobbyistCovered position, as disclosed
JOHN DEL GIORNO New —
GARY HEIMBERG New —
WILLIAM J SCHUYLER New —
SARAH J WALSH New —
KIMBERLY A WILLIAMS New —

Torts TOR

PHARMACEUTICALS

LobbyistCovered position, as disclosed
JOHN DEL GIORNO New —
GARY HEIMBERG New —
WILLIAM J SCHUYLER New —
SARAH J WALSH New —
KIMBERLY A WILLIAMS New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
GLAXOSMITHKLINE, PLC United Kingdom United Kingdom 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.